Faculty of Medicine, Northern Borders University, Arar, Saudi Arabia.
Department of Pharmaceutical Systems and Policy, School of Pharmacy, West Virginia University, Morgantown, WV, USA.
Breast Cancer Res Treat. 2018 Jan;167(1):183-193. doi: 10.1007/s10549-017-4477-0. Epub 2017 Sep 2.
This study assessed the association between the severity of diabetes complications using diabetes complications severity index (DCSI) and stage of breast cancer (BC) at diagnosis among elderly women with pre-existing diabetes and incident BC.
Using Surveillance, Epidemiology and End Results-Medicare data, we identified women with incident BC during 2004-2011 and pre-existing diabetes (N = 7729). Chi-square tests were used to test for group differences in stage of BC at diagnosis. Multinomial logistic regression was used to examine the associations between the severity of diabetes complications and stage of BC at diagnosis.
Overall, women with a DCSI = 2 and a DCSI ≥ 3 were more likely to be diagnosed at advanced stages as compared to those with no diabetes complications. In full adjusted association (after adding BC screening to the analysis model), the severity of diabetes complications was no longer an independent predictor of advanced stages at diagnosis. However, women with a DCSI = 2 were 26% more likely to be diagnosed at stage I (versus stage 0) of BC at diagnosis as compared to those without diabetes complications (OR 1.26, 95% CI 1.03-1.53).
The increased likelihood of having advanced-stage BC at diagnosis associated with severity of diabetes-related complications appears to be mediated by lower rates of breast cancer screening among elderly women with pre-existing diabetes complications. Therefore, reducing disparity in receiving breast cancer screening among elderly women with diabetes may reduce the risk of advanced-stage breast cancer diagnosis.
本研究评估了使用糖尿病并发症严重指数(DCSI)评估的糖尿病并发症严重程度与老年女性糖尿病合并新发乳腺癌(BC)诊断时 BC 分期之间的关系。
利用监测、流行病学和最终结果-医疗保险数据,我们确定了 2004 年至 2011 年间患有新发 BC 和预先存在糖尿病的女性(N=7729)。卡方检验用于检验诊断时 BC 分期的组间差异。多分类逻辑回归用于检查糖尿病并发症严重程度与诊断时 BC 分期之间的关联。
总体而言,与无糖尿病并发症的患者相比,DCSI=2 和 DCSI≥3 的患者更有可能被诊断为晚期。在完全调整的关联中(在分析模型中加入 BC 筛查后),糖尿病并发症的严重程度不再是诊断时晚期的独立预测因素。然而,与无糖尿病并发症的患者相比,DCSI=2 的患者诊断为 I 期(而非 0 期)BC 的可能性高 26%(OR 1.26,95%CI 1.03-1.53)。
与糖尿病相关并发症严重程度相关的、诊断时更有可能出现晚期 BC 的可能性,似乎是由患有预先存在的糖尿病并发症的老年女性中较低的乳腺癌筛查率介导的。因此,减少糖尿病老年女性接受乳腺癌筛查的差异可能会降低诊断为晚期乳腺癌的风险。